1. Home
  2. LZM vs PROK Comparison

LZM vs PROK Comparison

Compare LZM & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LZM
  • PROK
  • Stock Information
  • Founded
  • LZM 2021
  • PROK 2015
  • Country
  • LZM Isle of Man
  • PROK United States
  • Employees
  • LZM N/A
  • PROK N/A
  • Industry
  • LZM Metal Mining
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LZM Basic Materials
  • PROK Health Care
  • Exchange
  • LZM Nasdaq
  • PROK Nasdaq
  • Market Cap
  • LZM 431.4M
  • PROK 417.1M
  • IPO Year
  • LZM N/A
  • PROK N/A
  • Fundamental
  • Price
  • LZM $4.99
  • PROK $3.10
  • Analyst Decision
  • LZM Strong Buy
  • PROK Strong Buy
  • Analyst Count
  • LZM 1
  • PROK 4
  • Target Price
  • LZM $14.00
  • PROK $6.25
  • AVG Volume (30 Days)
  • LZM 183.9K
  • PROK 2.2M
  • Earning Date
  • LZM 08-11-2025
  • PROK 11-12-2025
  • Dividend Yield
  • LZM N/A
  • PROK N/A
  • EPS Growth
  • LZM N/A
  • PROK N/A
  • EPS
  • LZM N/A
  • PROK N/A
  • Revenue
  • LZM $416,323.00
  • PROK $527,000.00
  • Revenue This Year
  • LZM $611.56
  • PROK $471.74
  • Revenue Next Year
  • LZM $344.44
  • PROK N/A
  • P/E Ratio
  • LZM N/A
  • PROK N/A
  • Revenue Growth
  • LZM N/A
  • PROK N/A
  • 52 Week Low
  • LZM $2.90
  • PROK $0.46
  • 52 Week High
  • LZM $7.29
  • PROK $7.13
  • Technical
  • Relative Strength Index (RSI)
  • LZM 38.85
  • PROK 54.09
  • Support Level
  • LZM $5.16
  • PROK $2.90
  • Resistance Level
  • LZM $5.62
  • PROK $3.48
  • Average True Range (ATR)
  • LZM 0.33
  • PROK 0.24
  • MACD
  • LZM -0.12
  • PROK -0.02
  • Stochastic Oscillator
  • LZM 4.72
  • PROK 44.12

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: